rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Boris Gorelik

VP, BD and Strategic Programs

Company insider

Files Form 4 as: VP, BD and Strategic Programs, Kamada.

In numbers

Trades disclosed
18
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
7 Apr 2026
Last trade
27 Aug 2026
Last filed
24 Sep 2026

Companies traded

Where they are an officer
KMDA KamadaOfficer · Biotechnology · last 27 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
27 Aug 2026filed 24 Sep 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
27 Aug 2026filed 24 Sep 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code A—3,750filing
7 Apr 2026filed 9 Apr 2026KMDA Kamadaoption or derivative · BiotechnologySEC FORM 4 Code D—3,750filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Ishay DavidiDirector and 10% owner · Director and 10% owner at Kamada, filing Form 4 there in the last year
Lilach Asher-TopilskyDirector · Director at Kamada, filing Form 4 there in the last year
Uri BotzerDirector · Director at Kamada, filing Form 4 there in the last year
Amir LondonChief Executive Officer · Chief Executive Officer at Kamada, filing Form 4 there in the last year
Karnit GoldwasserDirector · Director at Kamada, filing Form 4 there in the last year